Innobic and TISTR Partner to Develop Thai-Strain Probiotics

According to a report from Thai Post published on September 7, 2026, Innobic (Asia) and the Thailand Institute of Scientific and Technological Research (TISTR) have entered into a partnership to research and develop a new line of 'Functional Probiotics' derived from Thai microbial strains. The primary objective of this initiative is to create health-focused products capable of assisting in the reduction of blood lipid levels.

For residents and travelers in Thailand, this development highlights the country's growing investment in biotechnology and functional food research. As the market for health-conscious products expands, this collaboration may eventually lead to a wider availability of locally produced, scientifically backed probiotic supplements in Thai pharmacies and health stores.

While the partnership marks a significant step in domestic biotech innovation, several details remain to be confirmed. Specifically, the timeline for the commercial release of these products, the specific microbial strains being utilized, and the regulatory approval process for these health claims have not yet been disclosed. Consumers should await further announcements regarding the availability and clinical validation of these Thai-strain probiotics before making changes to their health or dietary routines.